International Journal of Clinical Pharmacy

, Volume 39, Issue 6, pp 1171–1174 | Cite as

Clinical knowledge of community pharmacists in Croatia for detecting drug-related problems

  • Lovre Zekan
  • Arijana Mestrovic
  • Ana Seselja Perisin
  • Mate Portolan
  • Nada Jambrek
  • Silvana Jager
  • Martina Sepetavc
  • Darko Modun
Short Research Report

Abstract

Background Drug-related problems (DRPs) interfere with patient’s health outcomes and have a negative impact on healthcare resources. Successful management of DRPs is an essential part of pharmaceutical care. Pharmacists should have adequate clinical knowledge in order to effectively implement pharmaceutical care and manage DRPs. Objective To determine the clinical knowledge of community pharmacists in Croatia to detect and resolve DRPs. Method A sample of 302 community pharmacists have anonymously and voluntarily completed the validated survey-based clinical knowledge measurement tool. For each completed survey, all statements were scored individually, and a total score was calculated. The lowest possible total score was 0 and the highest was 80. Higher survey score indicates a higher level of clinical knowledge to detect and resolve a DRP. Results All community pharmacists had a mean score of 45.5 ± 8.6, while pharmacists from a pharmacy chain with mandatory education had a higher mean score of 50.2 ± 6.5. Multivariate linear regression revealed that only additional education (β = 0.272, p < 0.001) is associated with a higher mean score, while age and gender have no influence on the survey score. Conclusion Additional education of community pharmacists could increase their clinical knowledge to detect and resolve DRPs.

Keywords

Clinical knowledge Community pharmacy Croatia Drug-related problems Survey 

Notes

Acknowledgements

The authors thank all participating community pharmacists and students for making this study possible, and Josipa Bukic, Doris Rusic and Dario Leskur for their support.

Funding

No specific funding was received for this study.

Conflicts of interest

All authors declare that they have no conflict of interest.

Supplementary material

11096_2017_546_MOESM1_ESM.pdf (224 kb)
Supplementary material 1 (PDF 223 kb)

References

  1. 1.
    van Mil JW, Horvat N, Westerlund T. The PCNE Classification V 8.0. Pharmaceutical Care Network Europe. 2017. http://www.pcne.org/upload/files/211_PCNE_classification_V8-0.pdf. Accessed 22 May 2017.
  2. 2.
    Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995;155(18):1949–56.CrossRefPubMedGoogle Scholar
  3. 3.
    Cousins D, Kijlstra N, Walser S. Pharmaceutical care—policies and practices for a safer, more responsible and cost-effective health system. European Directorate for the Quality of Medicines & HealthCare, EDQM, Council of Europe. 2012. https://www.edqm.eu/medias/fichiers/policies_and_practices_for_a_safer_more_responsibl.pdf. Accessed 22 May 2017.
  4. 4.
    Allemann SS, van Mil JW, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544–55. doi: 10.1007/s11096-014-9933-x.CrossRefPubMedGoogle Scholar
  5. 5.
    Williams M, Peterson GM, Tenni PC, Bindoff IK. A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems. Int J Pharm Pract. 2012;20(4):238–48. doi: 10.1111/j.2042-7174.2012.00188.x.CrossRefPubMedGoogle Scholar
  6. 6.
    Lamsam GD, Kropff MA. Community pharmacists’ assessments and recommendations for treatment in four case scenarios. Ann Pharmacother. 1998;32(4):409–16.CrossRefPubMedGoogle Scholar
  7. 7.
    Mucalo I, Hadziabdic MO, Govorcinovic T, Saric M, Bruno A, Bates I. The development of the croatian competency framework for pharmacists. Am J Pharm Educ. 2016;80(8):134. doi: 10.5688/ajpe808134.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Seselja-Perisin A, Mestrovic A, Klinar I, Modun D. Health care professionals’ and students’ attitude toward collaboration between pharmacists and physicians in Croatia. Int J Clin Pharm. 2016;38(1):16–9. doi: 10.1007/s11096-015-0215-z.CrossRefPubMedGoogle Scholar
  9. 9.
    Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci. 1999;21(6):245–50.CrossRefPubMedGoogle Scholar
  10. 10.
    Currie JD, Chrischilles EA, Kuehl AK, Buser RA. Effect of a training program on community pharmacists’ detection of and intervention in drug-related problems. J Am Pharm Assoc (Wash). 1997;NS37(2):182–91.CrossRefGoogle Scholar
  11. 11.
    National Health Care Strategy 2012.-2020. Zagreb: Ministry of Health of the Republic of Croatia; 2012.Google Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Lovre Zekan
    • 1
    • 2
  • Arijana Mestrovic
    • 2
    • 3
  • Ana Seselja Perisin
    • 2
  • Mate Portolan
    • 1
    • 2
    • 4
  • Nada Jambrek
    • 5
  • Silvana Jager
    • 6
  • Martina Sepetavc
    • 7
  • Darko Modun
    • 2
  1. 1.Split-Dalmatia County PharmacySplitCroatia
  2. 2.Department of PharmacyUniversity of Split School of MedicineSplitCroatia
  3. 3.Pharmaexpert LLCZagrebCroatia
  4. 4.Croatian Chamber of PharmacistsZagrebCroatia
  5. 5.City Pharmacy ZagrebZagrebCroatia
  6. 6.Jadran Pharmacy RijekaRijekaCroatia
  7. 7.FarmaciaZagrebCroatia

Personalised recommendations